Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Affiliations

• ¹ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA jut9021@med.cornell.edu.
• ² Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
• ³ Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
• ⁴ Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
• ⁵ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
• ⁶ IRCCS San Raffaele Scientific Institute, Milan, Italy.
• ⁷ Division of Pathology, Department of Pathophysiology and Transplantation, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
• ⁸ Department of Pathology, Texas Tech University, El Paso, TX, USA.